Premier Diagnostic Health Services Inc.: Private Placement Extended

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Nov. 29, 2012) - Premier Diagnostic Health Services Inc. ("PDH") (CNSX:PDH) today announced that it is extending its July 27, 2012 offering to accredited investors. The previously announced offering consisted of 7,500,000 units at $0.10 per unit for aggregate proceeds of $750,000. Each unit consisted of one (1) share of PDH and one (1) warrant.

The revised terms of the extended offering are: 2,500,000 units to be sold at a price of $0.20 per unit, with each unit consisting of two (2) shares of PDH valued at $0.10 per share and one (1) warrant. One (1) warrant is required for the purchase of an additional share at $0.15 per share, plus one (1) bonus share, for a total of two (2) shares per warrant redeemed. The warrants are non-transferable and will expire June 30, 2013. Warrants must be redeemed 30 days prior to shares trading on another exchange. Minimum subscription is $20,000 for 100,000 units.

This extended offering will now expire at 2:00 p.m. on March 31, 2013. The company may carry out periodic closings during the term of the offering.

The funds will be used to facilitate the Company's business plan as well as the use of proceeds described in the unit offering term sheet.

More details about the business plan, term sheet, subscription form, and authorized representatives are available on the company's website at www.premierdiagnostics.ca. Please visit us on Facebook at www.facebook.com/petctscan.

Except for historical information contained herein, this news release contains forward-looking statements that involve risks and uncertainties. Actual results may differ materially. More detailed information about potential factors that could affect financial results is included in the documents filed from time to time with the Canadian securities regulatory authorities by Premier. (Not for dissemination in the United States of America).

About Premier Diagnostic Health Services Inc. ("PDH")

Premier is a Canadian company accelerating international access to advanced medical diagnostic tools and skills. The company's vision is to provide services and partnership opportunities that support "improving medical decisions" around the world. The company's approach involves building long-term relationships covering management, quality, and financial services that are necessary to build, operate, and grow hospitals' diagnostic capacity and capability.